Evidence map›Paper›PMID 21056571›Full record

ArticleJournal of molecular and cellular cardiology2011

Loss of the AE3 anion exchanger in a hypertrophic cardiomyopathy model causes rapid decompensation and heart failure.

Nabeel J Al Moamen, Vikram Prasad, Ilona Bodi, Marian L Miller, Michelle L Neiman, Valerie M Lasko, Seth L Alper, David F Wieczorek, John N Lorenz, Gary E Shull

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular and cellular cardiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Potential Theranostic Roles of SLC4 Molecules in Human Diseases.International journal of molecular sciences · 2023
    Review
  4. The therapeutic importance of acid-base balance.Biochemical pharmacology · 2021
    Review
  5. Article
  6. NBCe1 NaWorld journal of cardiology · 2018
    Article
  7. Mouse models of SLC4-linked disorders of HCOAmerican journal of physiology. Cell physiology · 2018
    Review
  8. Article
  9. Article
  10. Investigation of SLA4A3 as a candidate gene for human retinal disease.Journal of negative results in biomedicine · 2016
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Nabeel J Al MoamenDepartment of Molecular Genetics, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.
Vikram Prasad
Ilona Bodi
Marian L Miller
Michelle L Neiman
Valerie M Lasko
Seth L Alper
David F Wieczorek
John N Lorenz
Gary E Shull
University of Cincinnati Medical Center · USHarvard University · US

Funding

Mouse Models for Ion Homeostasis Defects in HeartR01HL061974 · NHLBI · UNIVERSITY OF CINCINNATI · PI SHULL, GARY EDWARD · 1999 to 2010
$5.1M
MOLECULAR PHYSIOLOGY OF BAND 3 LIKE PROTEINS OF KIDNEYR37DK043495 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI ALPER, SETH LEO · 1998 to 2007
$3.0M
The Regulation of Sarcomeric Function by TropomyosinR01HL081680 · NHLBI · UNIVERSITY OF CINCINNATI · PI WIECZOREK, DAVID F · 2007 to 2010
$1.6M
MOLECULAR PHYSIOLOGY OF BAND 3-LIKE PROTEINS OF KIDNEYR01DK043495 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI ALPER, SETH LEO · 1991 to 1997
–
NHLBI NIH HHS HL061974NHLBI NIH HHS HL081680NHLBI NIH HHS R01 HL061974NHLBI NIH HHS R01 HL081680NIDDK NIH HHS DK043495NIDDK NIH HHS R37 DK043495
6 · The paper itself

Abstract

The AE3 Cl(-)/HCO(3)(-) exchanger is abundantly expressed in the sarcolemma of cardiomyocytes, where it mediates Cl(-)-uptake and HCO(3)(-)-extrusion. Inhibition of AE3-mediated Cl(-)/HCO(3)(-) exchange has been suggested to protect against cardiac hypertrophy; however, other studies indicate that AE3 might be necessary for optimal cardiac function. To test these hypotheses we crossed AE3-null mice, which appear phenotypically normal, with a hypertrophic cardiomyopathy mouse model carrying a Glu180Gly mutation in α-tropomyosin (TM180). Loss of AE3 had no effect on hypertrophy; however, survival of TM180/AE3 double mutants was sharply reduced compared with TM180 single mutants. Analysis of cardiac performance revealed impaired cardiac function in TM180 and TM180/AE3 mutants. TM180/AE3 double mutants were more severely affected and exhibited little response to β-adrenergic stimulation, a likely consequence of their more rapid progression to heart failure. Increased expression of calmodulin-dependent kinase II and protein phosphatase 1 and differences in methylation and localization of protein phosphatase 2A were observed, but were similar in single and double mutants. Phosphorylation of phospholamban on Ser16 was sharply increased in both single and double mutants relative to wild-type hearts under basal conditions, leading to reduced reserve capacity for β-adrenergic stimulation of phospholamban phosphorylation. Imaging analysis of isolated myocytes revealed reductions in amplitude and decay of Ca(2+) transients in both mutants, with greater reductions in TM180/AE3 mutants, consistent with the greater severity of their heart failure phenotype. Thus, in the TM180 cardiomyopathy model, loss of AE3 had no apparent anti-hypertrophic effect and led to more rapid decompensation and heart failure.

Indexed as

AnimalsAntiportersCalciumCalcium-Calmodulin-Dependent Protein Kinase Type 2Cardiomyopathy, HypertrophicCation Transport ProteinsFemaleHeart FailureImmunoblottingMaleMiceMice, Mutant StrainsMice, TransgenicMyocytes, CardiacPhosphoprotein PhosphatasesPhosphorylationAntiportersCalciumCalcium-Calmodulin-Dependent Protein Kinase Type 2Cation Transport ProteinsPhosphoprotein PhosphatasesSlc4a3 protein, mouseSlc9a1 protein, mouseSodium-Hydrogen Exchanger 1Sodium-Hydrogen Exchangers

Identifiers

PMID21056571
PMCPMC3019292
OpenAlexW2018374914

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.